İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2014 · article

Why Vitamin D in Alzheimer's Disease? The Hypothesis

Dergi Journal of Alzheimer s Disease
OpenAlex Üst %10
Yıl2014
Atıf96OpenAlex
Atıf102Semantic Scholar · 3 etkili
Yüzdelik%97,6
FWCI6,651,00 = dünya ortalaması

Veri kaynağı ayrımı

  • YÖKSİS dergi adıJournal of Alzheimer s Disease
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Scientists have worked for over a century to uncover the basis of Alzheimer's disease (AD) with the ultimate goal of discovering a treatment. However, none of the approaches utilized have defined the exact cause of the disease or an ultimate treatment for AD. In this review, we aim to define the role of vitamin D in AD from a novel and fundamental perspective and attempt to answer the following question: Why should we seriously consider "simple" vitamin D as a "fundamental factor" in AD? To answer this question, we explain the protective effects of vitamin D in the central nervous system and how the action of vitamin D and AD-type pathology overlap. Furthermore, we suggest that the role of vitamin D in AD includes not only vitamin D deficiency and vitamin D-related genes but also the disruption of vitamin D metabolism and action. This suggestion is supported by evidence that the disruption of vitamin D pathways mimic amyloid pathology. We define the term "inefficient utilization of vitamin D" as any alteration in vitamin D-related genes, including receptors, the enzymes related to vitamin D metabolism or the transporters of vitamin D, and we discuss the potential correlation of vitamin D status with the vulnerability of neurons to aging and neurodegeneration. Finally, in addition to the current knowledge that defines AD, we suggest that AD could be the result of a long-term hormonal imbalance in which the critical hormone is vitamin D, a secosteroid that has long been misnamed.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

96atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 50 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2021 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1Atıf 73 · OpenAlex
  2. 2021 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1.Atıf 73 · OpenAlex
  3. 2021 Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infectionAtıf 73 · OpenAlex
  4. 2021 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1Atıf 73 · OpenAlex
  5. 2021 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1Atıf 73 · OpenAlex
  6. 2021 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1Atıf 73 · OpenAlex
  7. 2018 Serum Vitamin D in patients with mild cognitive impairment and Alzheimer’s diseaseAtıf 56 · OpenAlex
  8. 2016 GC and VDR SNPs and Vitamin D Levels in Parkinson s Disease The Relevance to Clinical FeaturesAtıf 53 · OpenAlex
  9. 2016 GC and VDR SNPs and Vitamin D Levels in Parkinson\u2019s Disease: The Relevance to Clinical FeaturesAtıf 53 · OpenAlex
  10. 2017 GC and VDR SNPs and Vitamin D Levels in Parkinson’xxs Disease: The Relevance to Clinical FeaturesAtıf 52 · OpenAlex

Yazarlar

Yazar bilgisi yok.